Attached files

file filename
EX-31.1 - CERTIFICATION OF THE COMPANY'S CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - VistaGen Therapeutics, Inc.ex31-1.htm
10-K - ANNUAL REPORT - VistaGen Therapeutics, Inc.vsta10k_mar312016.htm
EX-31.2 - CERTIFICATION OF THE COMPANY'S CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - VistaGen Therapeutics, Inc.ex31-2.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUTING FIRM - VistaGen Therapeutics, Inc.ex23-1.htm
EX-10.117 - SECOND AMENDMENT TO EMPLOYMENT AGREEMENT BY AND BETWEEN VISTAGEN THERAPEUTICS, INC. AND H. RALPH SNODGRASS, PH.D., - VistaGen Therapeutics, Inc.ex10-117.htm
EX-10.116 - SECOND AMENDMENT TO EMPLOYMENT AGREEMENT BY AND BETWEEN VISTAGEN THERAPEUTICS, INC. AND SHAWN K. SINGH - VistaGen Therapeutics, Inc.ex10-116.htm
EX-10.112 - INDEMNIFICATION AGREEMENT EFFECTIVE APRIL 8, 2016 BETWEEN THE COMPANY AND JERRY B. GIN - VistaGen Therapeutics, Inc.ex10-112.htm
EXHIBIT 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of VistaGen Therapeutics, Inc. (the “Company”) hereby certifies, to such officer’s knowledge, that:
 
(i) the accompanying Annual Report on Form 10-K of the Company for the annual period ended March 31, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
 
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


June 24, 2016

/s/ Shawn K. Singh
Shawn K. Singh, JD
Principal Executive Officer


/s/ Jerrold D. Dotson
Jerrold D. Dotson
Principal Financial Officer